| Laura Deschamps, | |
|
1240 S Cedar Crest Blvd Ste 307, Allentown, PA 18103-6263 | |
| (610) 402-1757 | |
| (610) 402-9089 |
| Full Name | Laura Deschamps |
|---|---|
| Gender | Female |
| Speciality | Pain Management |
| Experience | 8 Years |
| Location | 1240 S Cedar Crest Blvd Ste 307, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427402429 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
Policies requiring landlords to disclose a rental unit's history with bedbugs may raise costs to landlords over the short-term, but over the long-term they are an effective way to reduce infestations and lower costs, according to a just-published study.
Intermittent fasting may provide significant health benefits, including improved cardiometabolic health, improved blood chemistry and reduced risk for diabetes, new research conducted in part at Texas State University indicates.
Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 2 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
Policies requiring landlords to disclose a rental unit's history with bedbugs may raise costs to landlords over the short-term, but over the long-term they are an effective way to reduce infestations and lower costs, according to a just-published study.
Intermittent fasting may provide significant health benefits, including improved cardiometabolic health, improved blood chemistry and reduced risk for diabetes, new research conducted in part at Texas State University indicates.
Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Deschamps, 2100 Mack Blvd, Allentown, PA 18103-5622 Ph: (484) 884-0617 | Laura Deschamps, 1240 S Cedar Crest Blvd Ste 307, Allentown, PA 18103-6263 Ph: (610) 402-1757 |
News Archive
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
Policies requiring landlords to disclose a rental unit's history with bedbugs may raise costs to landlords over the short-term, but over the long-term they are an effective way to reduce infestations and lower costs, according to a just-published study.
Intermittent fasting may provide significant health benefits, including improved cardiometabolic health, improved blood chemistry and reduced risk for diabetes, new research conducted in part at Texas State University indicates.
Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 2 days ago
Nathan Maltezos, DO Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 S 18th St, Allentown, PA 18104 Phone: 610-628-8372 Fax: 610-628-8648 | |
Jian Chen, M.D.,PH.D Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1146 S. Cedar Crest Blvd, 2nd Floor, Allentown, PA 18103 Phone: 610-366-9000 Fax: 610-366-9229 | |
Dr. Kenneth J Choquette, D.O. Pain Medicine Medicare: Medicare Enrolled Practice Location: 1251 S Cedar Crest Blvd, Ste 203, Allentown, PA 18103 Phone: 610-439-1662 Fax: 610-439-8397 |